Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-010327)

Filing Details

Accession Number:: 0001181431-12-010327
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-21 14:46:07
Reporting Period:: 2012-02-17

Filing Date:: 2012-02-21
Accepted Time:: 2012-02-21 14:46:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235612	Laurie Brlas	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-17	4,650	$23.44	21,963	No	4	M	Direct
Common Stock	Disposition	2012-02-17	4,650	$94.78	17,313	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option Right to Buy	Disposition	2012-02-17	4,650	$0.00	4,650	$23.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-11-04	2017-10-30	No	4	M	Direct

Footnotes

The price in column 4 is a weighted average. The prices actually received ranged from $94.38 to $95.08. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.